A. Ahmed, D. Bararia, S. Vinayak, M. Yameen, S. Biswas et al., Plasmodium falciparum Isolates in India Exhibit a Progressive Increase in Mutations Associated with Sulfadoxine-Pyrimethamine Resistance, Antimicrobial Agents and Chemotherapy, vol.48, issue.3, pp.879-889, 2004.
DOI : 10.1128/AAC.48.3.879-889.2004

A. Ahmed, M. K. Das, V. Dev, M. A. Saifi, . Wajihullah et al., Quadruple Mutations in Dihydrofolate Reductase of Plasmodium falciparum Isolates from Car Nicobar Island, India, Antimicrobial Agents and Chemotherapy, vol.50, issue.4, pp.1546-1549, 2006.
DOI : 10.1128/AAC.50.4.1546-1549.2006

M. Alecrim, W. Alecrim, and V. Macêdo, Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region, Revista da Sociedade Brasileira de Medicina Tropical, vol.32, issue.1, pp.67-68, 1999.
DOI : 10.1590/S0037-86821999000100013

N. M. Anstey, B. Russell, T. W. Yeo, and R. N. Price, The pathophysiology of vivax malaria, Trends in Parasitology, vol.25, issue.5, pp.220-227, 2009.
DOI : 10.1016/j.pt.2009.02.003

A. Auliff, D. W. Wilson, B. Russell, Q. Gao, N. Chen et al., Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs. Am, J. Trop. Med. Hyg, vol.75, pp.617-621, 2006.

J. K. Baird, H. Basri, . Purnomo, M. J. Bangs, B. Subianto et al., Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg, vol.44, pp.547-552, 1991.

C. Barnadas, M. Tichit, C. Bouchier, A. Ratsimbasoa, L. Randrianasolo et al., Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine, Malaria Journal, vol.7, issue.1, p.35, 2008.
DOI : 10.1186/1475-2875-7-35

J. D. Chulay, W. M. Watkins, and D. G. Sixsmith, Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro, Am. J. Trop. Med. Hyg, vol.33, pp.325-330, 1984.

P. Collignon, Chloroquine Resistance in Plasmodium vlvax, Journal of Infectious Diseases, vol.164, issue.1, pp.222-223, 1991.
DOI : 10.1093/infdis/164.1.222

P. E. De-pécoulas, R. Tahar, T. Ouatas, A. Mazabraud, and L. K. Basco, Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance, Molecular and Biochemical Parasitology, vol.92, issue.2, pp.265-273, 1998.
DOI : 10.1016/S0166-6851(97)00247-8

P. E. De-pécoulas, R. Tahar, P. Yi, K. H. Thai, and L. K. Basco, Genetic variation of the dihydrofolate reductase gene in Plasmodium vivax in Snoul, northeastern Cambodia, Acta Tropica, vol.92, issue.1, pp.1-6, 2004.
DOI : 10.1016/j.actatropica.2004.03.011

F. S. De-santana-filho, A. R. Arcanjo, Y. M. Chehuan, M. R. Costa, F. E. Martinez-espinosa et al., , Brazilian Amazon, Emerging Infectious Diseases, vol.13, issue.7, pp.1125-1126, 2007.
DOI : 10.3201/eid1307.061386

A. Djimdé, O. K. Doumbo, J. F. Cortese, K. Kayentao, S. Doumbo et al., A Molecular Marker for Chloroquine-Resistant Falciparum Malaria, New England Journal of Medicine, vol.344, issue.4, pp.257-263, 2001.
DOI : 10.1056/NEJM200101253440403

A. Djimdé, O. K. Doumbo, R. W. Steketee, and C. V. Plowe, Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria, The Lancet, vol.358, issue.9285, pp.890-891, 2001.
DOI : 10.1016/S0140-6736(01)06040-8

A. A. Djimdé, A. Dolo, A. Ouattara, S. Diakité, C. V. Plowe et al., Molecular Diagnosis of Resistance to Antimalarial Drugs during Epidemics and in War Zones, The Journal of Infectious Diseases, vol.190, issue.4, pp.853-855, 2004.
DOI : 10.1086/422758

E. B. Doberstyn, C. Teerakiartkamjorn, R. G. Andre, P. Phintuyothin, and S. Noeypatimanondh, Treatment of vivax malaria with sulfadoxine-pyrimethamine and with pyrimethamine alone, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.73, issue.1, pp.15-17, 1979.
DOI : 10.1016/0035-9203(79)90121-4

G. H. Edrissian, A. Afshar, A. Sayedzadeh, G. Mohsseni, and M. T. Satvat, Assessment of the response in vivo and in vitro of Plasmodium falciparum to sulphadoxine?pyrimethamine in the malarious areas of Iran, J. Trop. Med. Hyg, vol.96, pp.237-240, 1993.

S. J. Foote, D. Galatis, and A. F. Cowman, Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance., Proc. Natl. Acad. Sci. USA, pp.3014-3017, 1990.
DOI : 10.1073/pnas.87.8.3014

M. Garg, N. Gopinathan, P. Bodhe, and N. A. Kshirsagar, Vivax malaria resistant to chloroquine: case reports from Bombay, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.89, issue.6, pp.656-657, 1995.
DOI : 10.1016/0035-9203(95)90432-8

A. Gregson and C. V. Plowe, Mechanisms of Resistance of Malaria Parasites to Antifolates, Pharmacological Reviews, vol.57, issue.1, pp.117-145, 2005.
DOI : 10.1124/pr.57.1.4

M. D. Hastings and C. H. Sibley, Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax, Proc. Natl. Acad. Sci. USA 99, pp.13137-13141, 2002.
DOI : 10.1073/pnas.182295999

M. D. Hastings, K. M. Porter, J. D. Maguire, I. Susanti, W. Kania et al., from Indonesia and Therapeutic Response to Sulfadoxine plus Pyrimethamine, The Journal of Infectious Diseases, vol.189, issue.4, pp.744-750, 2004.
DOI : 10.1086/381397

URL : http://jid.oxfordjournals.org/cgi/content/short/189/4/744

M. D. Hastings, J. D. Maguire, M. J. Bangs, P. A. Zimmerman, J. C. Reeder et al., Novel Plasmodium vivax dhfr Alleles from the Indonesian Archipelago and Papua New Guinea: Association with Pyrimethamine Resistance Determined by a Saccharomyces cerevisiae Expression System, Antimicrobial Agents and Chemotherapy, vol.49, issue.2, pp.733-740, 2005.
DOI : 10.1128/AAC.49.2.733-740.2005

V. N. Hawkins, H. Joshi, K. Rungsihirunrat, K. Na-bangchang, and C. H. Sibley, Antifolates can have a role in the treatment of Plasmodium vivax, Trends in Parasitology, vol.23, issue.5, pp.213-222, 2007.
DOI : 10.1016/j.pt.2007.03.002

S. I. Hay, C. A. Guerra, A. J. Tatem, A. M. Noor, and R. W. Snow, The global distribution and population at risk of malaria: past, present, and future, The Lancet Infectious Diseases, vol.4, issue.6, pp.327-336, 2004.
DOI : 10.1016/S1473-3099(04)01043-6

A. Heidari, S. Dittrich, T. Jelinek, A. Kheirandish, K. Banihashemi et al., Genotypes and in vivo resistance of Plasmodium falciparum isolates in an endemic region of Iran, Parasitology Research, vol.187, issue.11, pp.589-592, 2007.
DOI : 10.1007/s00436-006-0291-z

M. Imwong, S. Pukrittakayamee, S. Looareesuwan, G. Pasvol, J. Poirreiz et al., Association of Genetic Mutations in Plasmodium vivax dhfr with Resistance to Sulfadoxine-Pyrimethamine: Geographical and Clinical Correlates, Antimicrobial Agents and Chemotherapy, vol.45, issue.11, pp.3122-3127, 2001.
DOI : 10.1128/AAC.45.11.3122-3127.2001

M. Imwong, S. Pukrittayakamee, L. Rénia, F. Letourneur, J. P. Charlieu et al., Novel Point Mutations in the Dihydrofolate Reductase Gene of Plasmodium vivax: Evidence for Sequential Selection by Drug Pressure, Antimicrobial Agents and Chemotherapy, vol.47, issue.5, pp.1514-1521, 2003.
DOI : 10.1128/AAC.47.5.1514-1521.2003

M. Imwong, S. Pukrittayakamee, Q. Cheng, C. Moore, S. Looareesuwan et al., Limited Polymorphism in the Dihydropteroate Synthetase Gene (dhps) of Plasmodium vivax Isolates from Thailand, Antimicrobial Agents and Chemotherapy, vol.49, issue.10, pp.4393-4395, 2005.
DOI : 10.1128/AAC.49.10.4393-4395.2005

T. Jelinek, A. H. Kilian, J. Curtis, M. T. Duraisingh, G. Kabagambe et al., Plasmodium falciparum: selection of serine 108 of dihydrofolate reductase during treatment of uncomplicated malaria with cotrimoxazole in Ugandan children, Am. J. Trop. Med. Hyg, vol.61, pp.125-130, 1999.

S. Kaur, S. K. Prajapati, K. Kalyanaraman, A. Mohmmed, H. Joshi et al., Plasmodium vivax dihydrofolate reductase point mutations from the Indian subcontinent, Acta Tropica, vol.97, issue.2, pp.174-180, 2006.
DOI : 10.1016/j.actatropica.2005.10.003

S. M. Kiara, J. Okombo, V. Masseno, L. Mwai, I. Ochola et al., In Vitro Activity of Antifolate and Polymorphism in Dihydrofolate Reductase of Plasmodium falciparum Isolates from the Kenyan Coast: Emergence of Parasites with Ile-164-Leu Mutation, Antimicrobial Agents and Chemotherapy, vol.53, issue.9, pp.3793-3798, 2009.
DOI : 10.1128/AAC.00308-09

L. Khatoon, F. N. Baliraine, M. Bonizzoni, S. A. Malik, and G. Yan, Prevalence of antimalarial drug resistance mutations in Plasmodium vivax and P. Falciparum from a malaria-endemic area of Pakistan, Am. J. Trop. Med. Hyg, vol.81, pp.525-528, 2009.

P. Kongsaeree, P. Khongsuk, U. Leartsakulpanich, P. Chitnumsub, B. Tarnchompoo et al., Crystal structure of dihydrofolate reductase from Plasmodium vivax: Pyrimethamine displacement linked with mutation-induced resistance, Proc. Natl. Acad. Sci. USA, pp.13046-13051, 2005.
DOI : 10.1073/pnas.0501747102

M. Korsinczky, K. Fischer, N. Chen, J. Baker, K. Rieckmann et al., Sulfadoxine Resistance in Plasmodium vivax Is Associated with a Specific Amino Acid in Dihydropteroate Synthase at the Putative Sulfadoxine-Binding Site, Antimicrobial Agents and Chemotherapy, vol.48, issue.6, pp.2214-2222, 2004.
DOI : 10.1128/AAC.48.6.2214-2222.2004

J. G. Kublin, F. K. Dzinjalamala, D. D. Kamwendo, E. M. Malkin, J. F. Cortese et al., Malaria, The Journal of Infectious Diseases, vol.185, issue.3, pp.380-388, 2002.
DOI : 10.1086/338566

J. G. Kublin, J. F. Cortese, E. M. Njunju, R. A. Mukadam, J. J. Wirima et al., Malaria after Cessation of Chloroquine Use in Malawi, The Journal of Infectious Diseases, vol.187, issue.12, pp.1870-1875, 2003.
DOI : 10.1086/375419

D. Kyabayinze, A. Cattamanchi, M. R. Kamya, P. J. Rosenthal, and G. Dorsey, Validation of a simplified method for using molecular markers to predict sulfadoxine?pyrimethamine treatment failure in African children with falciparum malaria, Am. J. Trop. Med. Hyg, vol.69, pp.247-252, 2003.

J. D. Maguire, I. W. Sumawinata, S. Masbar, B. Laksana, P. Prodjodipuro et al., Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia, The Lancet, vol.360, issue.9326, pp.58-60, 2002.
DOI : 10.1016/S0140-6736(02)09336-4

. Marlar-than, . Myat-phone-kyaw, . Aye-yu-soe, . Khaing-khaing-gyi, . Ma-sabai et al., Development of resistance to chloroquine by Plasmodium vivax in Myanmar, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.89, issue.3, pp.307-308, 1995.
DOI : 10.1016/0035-9203(95)90556-1

T. F. Mccutchan, J. A. Welsh, J. B. Dame, I. A. Quakyi, P. M. Graves et al., Mechanism of pyrimethamine resistance in recent isolates of Plasmodium falciparum., Antimicrobial Agents and Chemotherapy, vol.26, issue.5, pp.656-659, 1984.
DOI : 10.1128/AAC.26.5.656

M. Miao, Z. Yang, L. Cui, J. Ahlum, Y. Huang et al., Different Allele Prevalence in the Dihydrofolate Reductase and Dihydropteroate Synthase Genes in Plasmodium vivax Populations from China, American Journal of Tropical Medicine and Hygiene, vol.83, issue.6, pp.1206-1211, 2010.
DOI : 10.4269/ajtmh.2010.10-0259

I. Mueller, M. R. Galinski, J. K. Baird, J. M. Carlton, D. K. Kochar et al., Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite, The Lancet Infectious Diseases, vol.9, issue.9, pp.555-566, 2009.
DOI : 10.1016/S1473-3099(09)70177-X

T. Mutabingwa, A. Nzila, E. Mberu, E. Nduati, P. Winstanley et al., Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania, The Lancet, vol.358, issue.9289, pp.1218-1223, 2001.
DOI : 10.1016/S0140-6736(01)06344-9

. Myat-phone-kyaw, . Myint-oo, and . Myint-lwin, Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma), Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.87, issue.6, p.687
DOI : 10.1016/0035-9203(93)90294-Z

B. K. Na, H. W. Lee, S. U. Moon, T. S. In, K. Lin et al., Genetic variations of the dihydrofolate reductase gene of Plasmodium vivax in Mandalay Division, Myanmar, Parasitology Research, vol.65, issue.5, pp.321-325, 2005.
DOI : 10.1007/s00436-005-1364-0

M. Nateghpour, S. A. Sayedzadeh, G. H. Edrissian, A. Raeisi, A. Jahantigh et al., Evaluation of sensitivity of Plasmodium vivax to chloroquine, Iranian. J. Publ. Health, vol.36, pp.60-63, 2007.

A. M. Nzila, E. K. Mberu, J. Sulo, H. Dayo, P. A. Winstanley et al., Towards an Understanding of the Mechanism of Pyrimethamine-Sulfadoxine Resistance in Plasmodium falciparum: Genotyping of Dihydrofolate Reductase and Dihydropteroate Synthase of Kenyan Parasites, Antimicrobial Agents and Chemotherapy, vol.44, issue.4, pp.991-996, 2000.
DOI : 10.1128/AAC.44.4.991-996.2000

A. Nzila, The past, present and future of antifolates in the treatment of Plasmodium falciparum infection, Journal of Antimicrobial Chemotherapy, vol.57, issue.6, pp.1043-1054, 2006.
DOI : 10.1093/jac/dkl104

D. S. Peterson, D. Walliker, and T. E. Wellems, Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria., Proc. Natl. Acad. Sci. USA, pp.9114-9118, 1988.
DOI : 10.1073/pnas.85.23.9114

E. J. Phillips, J. S. Keystone, and K. C. Kain, Failure of Combined Chloroquine and High-Dose Primaquine Therapy for Plasmodium vivax Malaria Acquired in Guyana, South America, Clinical Infectious Diseases, vol.23, issue.5, pp.1171-1173, 1996.
DOI : 10.1093/clinids/23.5.1171

C. V. Plowe, J. F. Cortese, A. Djimde, O. C. Nwanyanwu, W. M. Watkins et al., Dihydrofolate Reductase and Dihydropteroate Synthase and Epidemiologic Patterns of Pyrimethamine???Sulfadoxine Use and Resistance, The Journal of Infectious Diseases, vol.176, issue.6, pp.1590-1596, 1997.
DOI : 10.1086/514159

S. K. Prajapati, H. Joshi, V. Dev, and V. K. Dua, Molecular epidemiology of Plasmodium vivax anti-folate resistance in India, Malaria Journal, vol.10, issue.1, p.102, 2011.
DOI : 10.4269/ajtmh.2010.10-0004

S. K. Prajapati, A. Verma, T. Adak, R. S. Yadav, A. Kumar et al., Allelic dimorphism of Plasmodium vivax gam-1 in the Indian subcontinent, Malaria Journal, vol.5, issue.1, p.90, 2006.
DOI : 10.1186/1475-2875-5-90

R. N. Price and F. Nosten, Drug resistant falciparum malaria: clinical consequences and strategies for prevention, Drug Resistance Updates, vol.4, issue.3, pp.187-196, 2001.
DOI : 10.1054/drup.2001.0195

R. N. Price, E. Tjitra, C. A. Guerra, S. Yeung, N. J. White et al., Vivax malaria: neglected and not benign, Am. J. Trop. Med. Hyg, vol.77, pp.79-87, 2007.

P. Reddy and J. P. Flaherty, Malaria Relapses after Primaquine Prophylaxis, Emerging Infectious Diseases, vol.12, issue.11, pp.1795-1796, 2006.
DOI : 10.3201/eid1211.060613

K. Rungsihirunrat, C. H. Sibley, M. Mungthin, and K. Na-bangchang, Geographical distribution of amino acid mutations in Plasmodium vivax DHFR and DHPS from malaria endemic areas of Thailand, Am. J. Trop. Med. Hyg, vol.78, pp.462-467, 2008.

M. L. Schousboe, R. S. Rajakaruna, A. Salanti, H. C. Hapuarachchi, G. N. Galappaththy et al., Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka, Malaria Journal, vol.6, issue.1, p.28, 2007.
DOI : 10.1186/1475-2875-6-28

M. Schunk, W. P. Kumma, I. B. Miranda, M. E. Osman, S. Roewer et al., High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia, Malaria Journal, vol.5, issue.1, p.54, 2006.
DOI : 10.1186/1475-2875-5-54

I. K. Schwartz, E. M. Lackritz, and L. C. Patchen, Chloroquine-resistant Plasmodium vivax from Indonesia, N. Engl. J. Med, vol.324, p.927, 1991.

G. Snounou, S. Viriyakosol, X. P. Zhu, W. Jarra, L. Pinheiro et al., High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction, Molecular and Biochemical Parasitology, vol.61, issue.2, pp.315-320, 1993.
DOI : 10.1016/0166-6851(93)90077-B

S. G. Staedke, H. Sendagire, S. Lamola, M. R. Kamya, G. Dorsey et al., Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda, Tropical Medicine and International Health, vol.41, issue.5, pp.624-629, 2004.
DOI : 10.1046/j.1365-3156.2001.00751.x

S. Thaithong, S. W. Chan, S. Songsomboon, P. Wilairat, N. Seesod et al., Pyrimethamine resistant mutations in Plasmodium falciparum, Molecular and Biochemical Parasitology, vol.52, issue.2, pp.149-157, 1992.
DOI : 10.1016/0166-6851(92)90047-N

E. Tjitra, J. Baker, S. Suprianto, Q. Cheng, and N. M. Anstey, Therapeutic Efficacies of Artesunate-Sulfadoxine-Pyrimethamine and Chloroquine-Sulfadoxine-Pyrimethamine in Vivax Malaria Pilot Studies: Relationship to Plasmodium vivax dhfr Mutations, Antimicrobial Agents and Chemotherapy, vol.46, issue.12, pp.3947-3953, 2002.
DOI : 10.1128/AAC.46.12.3947-3953.2002

J. F. Trape, G. Pison, M. P. Preziosi, C. Enel, A. Desgrées-du-loû et al., Impact of chloroquine resistance on malaria mortality, Comptes Rendus de l'Acad??mie des Sciences - Series III - Sciences de la Vie, vol.321, issue.8, pp.689-697, 1998.
DOI : 10.1016/S0764-4469(98)80009-7

J. F. Trape, The public health impact of chloroquine resistance in Africa, Am. J. Trop. Med. Hyg, vol.64, pp.12-17, 2001.

N. Valecha, H. Joshi, A. Eapen, J. Ravinderan, A. Kumar et al., Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their Pvdhfr gene mutation pattern, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.100, issue.9, pp.831-837, 2006.
DOI : 10.1016/j.trstmh.2005.11.012

K. Van-den-abbeele, E. Van-den-enden, and J. Van-den-ende, Combined chloroquine and primaquine resistant Plasmodium vivax malaria in a patient returning from India, Ann. Soc. Belg. Med. Trop, vol.75, pp.73-74, 1995.

L. S. Vestergaard and P. Ringwald, Responding to the challenge of antimalarial drug resistance by routine monitoring to update national malaria treatment policies, Am. J. Trop. Med. Hyg, vol.77, pp.153-159, 2007.

P. Wang, C. S. Lee, R. Bayoumi, A. Djimde, O. Doumbo et al., Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins, Molecular and Biochemical Parasitology, vol.89, issue.2, pp.161-177, 1997.
DOI : 10.1016/S0166-6851(97)00114-X

T. E. Wellems and C. V. Plowe, Chloroquine???Resistant Malaria, The Journal of Infectious Diseases, vol.184, issue.6, pp.770-776, 2001.
DOI : 10.1086/322858

M. Whitby, G. Wood, J. R. Veenendaal, and K. Rieckmann, CHLOROQUINE-RESISTANT PLASMODIUM VIVAX, The Lancet, vol.334, issue.8676, p.1395, 1989.
DOI : 10.1016/S0140-6736(89)92002-3

B. L. Xu, Y. P. Su, L. Y. Shang, and H. W. Zhang, Malaria control in Henan Province, People's Republic of China, Am. J. Trop. Med. Hyg, vol.74, pp.564-567, 2006.

M. D. Young and R. W. Burgess, Pyrimethamine resistance in Plasmodium vivax malaria, Bull. World Health Organ, vol.20, pp.27-36, 1959.

S. Zakeri, S. T. Najafabadi, A. Zare, and N. D. Djadid, Detection of malaria parasites by nested PCR in south-eastern, Iran: evidence of highly mixed infections in Chahbahar district, Malar. J, vol.1, issue.2, 2002.

S. Zakeri, M. Afsharpad, T. Kazemzadeh, K. Mehdizadeh, A. Shabani et al., Association of pfcrt but not pfmdr1 alleles with chloroquine resistance in Iranian isolates of Plasmodium falciparum, Am. J. Trop. Med. Hyg, vol.78, pp.633-640, 2008.

S. Zakeri, S. R. Motmaen, M. Afsharpad, and N. D. Djadid, Molecular characterization of antifolates resistance-associated genes, (dhfr and dhps) in Plasmodium vivax isolates from the Middle East, Malaria Journal, vol.8, issue.1, p.20, 2009.
DOI : 10.1186/1475-2875-8-20

S. Zakeri, Q. Kakar, F. Ghasemi, A. Raeisi, W. Butt et al., Detection of high prevalence of mixed Plasmodium falciparum and P. Vivax infections by nested-PCR in Pakistan and Iran but not in Afghanistan, Indian J. Med. Res, vol.132, pp.23-27, 2010.

S. Zakeri, M. Afsharpad, F. Ghasemi, A. Raeisi, N. Safi et al., Molecular surveillance of Plasmodium vivax dhfr and dhps mutations in isolates from Afghanistan, Malaria Journal, vol.9, issue.1, p.75, 2010.
DOI : 10.1186/1475-2875-9-75

S. Zakeri, M. Afsharpad, F. Ghasemi, A. Raeisi, Q. Kakar et al., Plasmodium vivax: Prevalence of mutations associated with sulfadoxine???pyrimethamine resistance in Plasmodium vivax clinical isolates from Pakistan, Experimental Parasitology, vol.127, issue.1, pp.167-172, 2010.
DOI : 10.1016/j.exppara.2010.07.011

W. Zhang, L. Wang, L. Fang, J. Ma, Y. Xu et al., Spatial analysis of malaria in Anhui province, China, Malaria Journal, vol.7, issue.1, p.206, 2008.
DOI : 10.1186/1475-2875-7-206